Literature DB >> 1315033

Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine.

P Melchiorri1, M Maritati, L Negri, V Erspamer.   

Abstract

In experiments to evaluate responses to the activation of cerebral delta-opioid receptors, repeated daily injection of the selective delta-opioid agonist Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 ([D-Ala2]deltorphin II) into rat brain resulted in the development of tolerance, whereas repeated daily injection or continuous infusion of morphine resulted in sensitization to the behavioral activating effects of the delta-opioid agonist. Although the rats did not modify their spontaneous locomotor activity after morphine withdrawal, they became markedly hyperresponsive to the locomotor and stereotypy-producing effects of a challenge dose of the delta-opioid agonist. Sensitization to activation of delta-opioid receptors persisted for at least 60 days after discontinuing morphine treatment. These results show that the development of tolerance and long-term sensitization to opioids involves delta-opioid as well as mu-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315033      PMCID: PMC525557          DOI: 10.1073/pnas.89.9.3696

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  [125I][D-Ala2]deltorphin-I: a high affinity, delta-selective opioid receptor ligand.

Authors:  S Dupin; J A Tafani; H Mazarguil; J M Zajac
Journal:  Peptides       Date:  1991 Jul-Aug       Impact factor: 3.750

2.  Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment.

Authors:  M Babbini; M Gaiardi; M Bartoletti
Journal:  Neuropharmacology       Date:  1975-08       Impact factor: 5.250

3.  (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens.

Authors:  R Longoni; L Spina; A Mulas; E Carboni; L Garau; P Melchiorri; G Di Chiara
Journal:  J Neurosci       Date:  1991-06       Impact factor: 6.167

4.  Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.

Authors:  G Calenco-Choukroun; V Daugé; G Gacel; J Féger; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Regulation of neuropeptide gene expression.

Authors:  R H Goodman
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

6.  Neuroanatomical focus for morphine and enkephalin-induced hypermotility.

Authors:  A Pert; C Sivit
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

7.  Regulation of proenkephalin by Fos and Jun.

Authors:  J L Sonnenberg; F J Rauscher; J I Morgan; T Curran
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

8.  Locomotor activity in morphine-dependent and post-dependent rats.

Authors:  L S Brady; S G Holtzman
Journal:  Pharmacol Biochem Behav       Date:  1981-03       Impact factor: 3.533

9.  Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.

Authors:  E E Abdelhamid; A E Takemori
Journal:  Eur J Pharmacol       Date:  1991-06-06       Impact factor: 4.432

10.  Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions.

Authors:  L Stinus; G F Koob; N Ling; F E Bloom; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  5 in total

1.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

2.  Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Authors:  L Gendron; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

3.  Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.

Authors:  L Negri; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

4.  Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.

Authors:  L Negri; G Improta; R Lattanzi; R L Potenza; F Luchetti; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Behavioural and morphological evidence for the involvement of glial cell activation in delta opioid receptor function: implications for the development of opioid tolerance.

Authors:  Sarah V Holdridge; Stacey A Armstrong; Anna M W Taylor; Catherine M Cahill
Journal:  Mol Pain       Date:  2007-03-12       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.